R1 RCM Statistics

Total Valuation

CONMED has a market cap or net worth of $1.62 billion. The enterprise value is $2.47 billion.

Market Cap	1.62B
Enterprise Value	2.47B

Important Dates

The last earnings date was Wednesday, July 30, 2025, after market close.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	Jun 13, 2025

Share Statistics

CONMED has 30.95 million shares outstanding.

Current Share Class	30.95M
Shares Outstanding	30.95M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	114.82%
Float	30.66M

Valuation Ratios

The trailing PE ratio is 14.77 and the forward PE ratio is 11.44. CONMED's PEG ratio is 1.74.

PE Ratio	14.77
Forward PE	11.44
PS Ratio	1.22
Forward PS	1.12
PB Ratio	1.61
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.74

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	3,900
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.26% in the last 52 weeks. The beta is 1.17, so CONMED's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	-24.26%
50-Day Moving Average	53.18
200-Day Moving Average	61.58
Relative Strength Index (RSI)	54.44
Average Volume (20 Days)	518,662

Short Selling Information

The latest short interest is 846,967, so 2.74% of the outstanding shares have been sold short.

Short Interest	846,967
Short Previous Month	1.02M
Short % of Shares Out	2.74%
Short % of Float	2.76%
Short Ratio (days to cover)	4.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	123.90M
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 1.56%.

Dividend Per Share	$0.80
Dividend Yield	1.56%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	22.60%
Buyback Yield	n/a
Shareholder Yield	1.53%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for CONMED is $59.80, which is 14.36% higher than the current price. The consensus rating is "Hold".

Price Target	$59.80
Price Target Difference	14.36%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 10, 2001. It was a forward split with a ratio of 1.5:1.

Last Split Date	Sep 10, 2001
Split Type	Forward
Split Ratio	1.5:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a